Targeting hepatocellular carcinoma with MAGE-A3-specific TCR-engineered T cells: A therapeutic approach
Yun Zhou(Guangzhou First People's Hospital), Guolong Liu(Guangzhou First People's Hospital), Bei Zhang(Fudan University), Jun Su(First Affiliated Hospital of Jinan University), Biwen Wu(Guangzhou First People's Hospital), Xiaoning Gan(Guangxi Medical University), Wei Jiang(First Affiliated Hospital of Jinan University), Guobing Chen(Jinan University), Chanchan Xiao(First Affiliated Hospital of Jinan University), Rong Li(First Affiliated Hospital of Guangzhou Medical University), Lingyu Wei(East China University of Science and Technology)
Cited by 0
Related Papers
Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty
|Nature Aging|2022|151
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
|Journal of Innate Immunity|2017|122
Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs
|Acta Biomaterialia|2017|116
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
|Cell Death and Disease|2022|110
Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression
|Journal of Virology|2018|97